BlackRock Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$872M Sell
14,919,472
-22,593
-0.2% -$1.24M 0.42% 48
2016
Q3
$806M Buy
14,942,065
+365,557
+3% +$23.5M 0.41% 49
2016
Q2
$1.07B Sell
14,576,508
-563,456
-4% -$39.8M 0.56% 37
2016
Q1
$967M Buy
15,139,964
+38,123
+0.3% +$2.4M 0.52% 40
2015
Q4
$1.04B Sell
15,101,841
-184,720
-1% -$12.2M 0.57% 34
2015
Q3
$905M Buy
15,286,561
+882,495
+6% +$56M 0.53% 36
2015
Q2
$958M Sell
14,404,066
-1,701,287
-11% -$112M 0.52% 37
2015
Q1
$1.04B Buy
16,105,353
+243,646
+2% +$15.3M 0.56% 37
2014
Q4
$936M Buy
15,861,707
+763,983
+5% +$43.1M 0.5% 39
2014
Q3
$773M Sell
15,097,724
-349,278
-2% -$17.4M 0.45% 44
2014
Q2
$749M Buy
15,447,002
+2,246,709
+17% +$111M 0.43% 49
2014
Q1
$686M Buy
13,200,293
+850,624
+7% +$45.3M 0.43% 48
2013
Q4
$656M Sell
12,349,669
-2,737,682
-18% -$139M 0.42% 47
2013
Q3
$698M Buy
15,087,351
+857,443
+6% +$37.6M 0.47% 42
2013
Q2
$636M Buy
+14,229,908
New +$618M 0.48% 36

Other funds holding BMY

BlackRock Group's BMY Position: Q4 2016 in Review

BlackRock Group reduced its Bristol-Myers Squibb (BMY) stake by 0.15% in Q4 2016, selling an estimated $1.24M and leaving 14,919,472 shares worth $872M. The position accounts for 0.42% of the portfolio, ranked #48.

BlackRock Group first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.07B in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • BlackRock Group held 14,919,472 shares of Bristol-Myers Squibb worth $872M as of Q4 2016.
  • BlackRock Group sold 22,593 Bristol-Myers Squibb shares in Q4 2016, an estimated $1.24M.
  • Bristol-Myers Squibb made up 0.42% of BlackRock Group's portfolio in Q4 2016, its #48 holding.
  • BlackRock Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Bristol-Myers Squibb position peaked at $1.07B in Q2 2016.
  • 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.